Low Total Plasma Homocysteine Level in Relation to Malnutrition, Inflammation, and Outcome in Hemodialysis Patients

Kalantar-Zadeh, 2003, Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences, Am J Kidney Dis, 42, 864, 10.1016/j.ajkd.2003.07.016 Kopple, 2005, The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure, Am J Clin Nutr, 81, 10.1093/ajcn/81.6.1257 Pecoits-Filho, 2002, The malnutrition, inflammation, and atherosclerosis (MIA) syndrome—The heart of the matter, Nephrol Dial Transplant, 17, 28, 10.1093/ndt/17.suppl_11.28 Kalantar-Zadeh, 2004, Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients, Nephrol Dial Transplant, 19, 1507, 10.1093/ndt/gfh143 Iseki, 2002, Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients, Kidney Int, 61, 1887, 10.1046/j.1523-1755.2002.00324.x Iseki, 1997, Low diastolic blood pressure, hypoalbuminemia and risk of death in a cohort of chronic hemodialysis patients, Kidney Int, 51, 1212, 10.1038/ki.1997.165 Kopple, 1999, Body weight-for-height relationships predict mortality in maintenance hemodialysis patients, Kidney Int, 56, 1136, 10.1046/j.1523-1755.1999.00615.x Nygard, 1997, Plasma homocysteine levels and mortality in patients with coronary artery disease, N Engl J Med, 337, 230, 10.1056/NEJM199707243370403 Mallamaci, 2002, Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients, Kidney Int, 61, 609, 10.1046/j.1523-1755.2002.00144.x Bostom, 1997, Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study, Arterioscler Thromb Vasc Biol, 17, 2554, 10.1161/01.ATV.17.11.2554 Bachmann, 1995, Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients, J Am Soc Nephrol, 6, 121, 10.1681/ASN.V61121 Kalantar-Zadeh, 2004, A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients, J Am Soc Nephrol, 15, 442, 10.1097/01.ASN.0000107564.60018.51 Suliman, 2000, Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients, Kidney Int, 57, 1727, 10.1046/j.1523-1755.2000.00018.x Ducloux, 2006, Impact of malnutrition-inflammation on the association between homocysteine and mortality, Kidney Int, 69, 331, 10.1038/sj.ki.5000096 Fried, 2001, Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients, Am J Kidney Dis, 37, 337, 10.1053/ajkd.2001.21300 Wrone, 2001, An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease, Kidney Int, 60, 1106, 10.1046/j.1523-1755.2001.0600031106.x Suliman, 2004, Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy, Am J Kidney Dis, 44, 455, 10.1016/S0272-6386(04)00815-7 Suliman, 2003, Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: Influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus, Am J Kidney Dis, 41, S89, 10.1053/ajkd.2003.50093 Oishi, 2000, The significance of serum homocysteine levels in diabetic patients on haemodialysis, Nephrol Dial Transplant, 15, 851, 10.1093/ndt/15.6.851 Suliman, 2007, The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation, Nephrol Dial Transplant, 22, 209, 10.1093/ndt/gfl510